Reminders increase colorectal screening rates for vulnerable populations

This article originally appeared here.
Reminders Up Colorectal Screening Rates for Vulnerable
Reminders Up Colorectal Screening Rates for Vulnerable

(HealthDay News) -- Low-cost interventions relying upon mailings, text messages, and phone calls can increase adherence to colorectal cancer screening with fecal immunochemical tests (FIT) among vulnerable populations, according to a study published June 16 in JAMA Internal Medicine.

David W. Baker, M.D., from Northwestern University in Chicago, and colleagues randomized 450 patients seen in a network of community health centers who had previously completed a home FOBT (March 2011 through February 2012). Usual care included computerized reminders, standing orders for FIT tests, and clinician feedback on CRC screening rates. The intervention group additionally received (1) a mailed reminder letter, a free FIT with low-literacy instructions, and a postage-paid return envelope; (2) an automated telephone and text message FIT reminder; (3) another automated telephone and text reminder 2 weeks later when the FIT was not returned; and (4) personal telephone outreach after 3 months.

The researchers found that intervention patients were much more likely than to complete FOBT (82.2 percent versus 37.3 percent; P < .001), compared to those in usual care. For the 185 intervention patients completing screening, 10.2 percent completed prior to their due date (intervention was not needed), 39.6 percent within 2 weeks (after step 1 of intervention), 24.0 percent (after automated call/text reminder), and 8.4 percent (after personal call.

"It is possible to improve annual CRC screening for vulnerable populations with relatively low-cost strategies that are facilitated by health information technologies," the authors write.

Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs